内分泌科指南

订阅

MedSci主页 / 所有栏目 / 内分泌科指南

基层糖尿病微血管病变筛查与防治专家共识（2021年版）

2021-06-17 中国微循环学会 中国医学前沿杂志(电子版). 2021,13(06)

糖尿病

随着人们生活方式的改变和社会人口老龄化的加剧,糖尿病正成为一个全球范围内的慢性流行性疾病。据国际糖尿病联盟估计,到2030年全球范围内2型糖尿病（type 2 diabetes mellitus,T2

中文标题：

基层糖尿病微血管病变筛查与防治专家共识（2021年版）

发布机构：

中国微循环学会

发布日期：

2021-06-17

简要介绍：

随着人们生活方式的改变和社会人口老龄化的加剧,糖尿病正成为一个全球范围内的慢性流行性疾病。据国际糖尿病联盟估计,到2030年全球范围内2型糖尿病（type 2 diabetes mellitus,T2DM）患者的人数将会达到5.92亿,其中我国约有1.164亿糖尿病患者,居世界第一,糖尿病防治任务艰巨。糖尿病管理不仅要实现理想的血糖控制,更需要强调多重代谢危险因素的全面控制,以达到预防慢性并发症、提高患者生活质量和延长寿命的目的。 

相关资料下载：
[AttachmentFileName(sort=1, fileName=基层糖尿病微血管病变筛查与防治专家共识_2021年版_.pdf)] GetToolGuiderByIdResponse(projectId=1, id=6c4151c0021290b0, title=基层糖尿病微血管病变筛查与防治专家共识（2021年版）, enTitle=, guiderFrom=中国医学前沿杂志(电子版). 2021,13(06), authorId=0, author=, summary=随着人们生活方式的改变和社会人口老龄化的加剧,糖尿病正成为一个全球范围内的慢性流行性疾病。据国际糖尿病联盟估计,到2030年全球范围内2型糖尿病（type 2 diabetes mellitus,T2, cover=https://img.medsci.cn/2021715/1626284164609_2020535.jpg, journalId=0, articlesId=null, associationId=1614, associationName=中国微循环学会, associationIntro=, copyright=0, guiderPublishedTime=Thu Jun 17 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #666666;">随着人们生活方式的改变和社会人口老龄化的加剧,糖尿病正成为一个全球范围内的慢性流行性疾病。据国际糖尿病联盟估计,到2030年全球范围内2型糖尿病（type 2 diabetes mellitus,T2DM）患者的人数将会达到5.92亿</span><span style="color: #666666;">,其中我国约有1.164亿糖尿病患者,居世界第一,糖尿病防治任务艰巨。糖尿病管理不仅要实现理想的血糖控制,更需要强调多重代谢危险因素的全面控制,以达到预防慢性并发症、提高患者生活质量和延长寿命的目的。&nbsp;</span></p>, tagList=[TagDto(tagId=216, tagName=糖尿病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=216, guiderKeyword=糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9401, appHits=215, showAppHits=0, pcHits=569, showPcHits=9186, likes=1, shares=23, comments=15, approvalStatus=1, publishedTime=Thu Jul 15 01:51:49 CST 2021, publishedTimeString=2021-06-17, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Jul 15 01:36:11 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 13:11:30 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=基层糖尿病微血管病变筛查与防治专家共识_2021年版_.pdf)])
基层糖尿病微血管病变筛查与防治专家共识_2021年版_.pdf
下载请点击：
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1204233, encodeId=5f0d12042331f, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14da2397323, createdName=12347d7bm83(暂无昵称), createdTime=Sun Mar 20 06:56:21 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080637, encodeId=1246108063e69, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:52:25 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078203, encodeId=301310e8203ae, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93086392192, createdName=ms6000000137745448, createdTime=Wed Dec 08 20:31:10 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070958, encodeId=e0ae10e095834, content=学习了，很有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b1a2235083, createdName=121304f3m09暂无昵称, createdTime=Wed Nov 17 06:20:36 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065595, encodeId=8fd3106559515, content=指南很新，正是我非常需要的，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=729f5602417, createdName=苹果🍎ms2000000115919235, createdTime=Sun Oct 31 21:00:55 CST 2021, time=2021-10-31, status=1, ipAttribution=)]
    2022-03-20 12347d7bm83(暂无昵称)

    好资料

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1204233, encodeId=5f0d12042331f, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14da2397323, createdName=12347d7bm83(暂无昵称), createdTime=Sun Mar 20 06:56:21 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080637, encodeId=1246108063e69, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:52:25 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078203, encodeId=301310e8203ae, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93086392192, createdName=ms6000000137745448, createdTime=Wed Dec 08 20:31:10 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070958, encodeId=e0ae10e095834, content=学习了，很有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b1a2235083, createdName=121304f3m09暂无昵称, createdTime=Wed Nov 17 06:20:36 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065595, encodeId=8fd3106559515, content=指南很新，正是我非常需要的，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=729f5602417, createdName=苹果🍎ms2000000115919235, createdTime=Sun Oct 31 21:00:55 CST 2021, time=2021-10-31, status=1, ipAttribution=)]
    2021-12-16 龙珠

    学习好资料

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1204233, encodeId=5f0d12042331f, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14da2397323, createdName=12347d7bm83(暂无昵称), createdTime=Sun Mar 20 06:56:21 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080637, encodeId=1246108063e69, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:52:25 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078203, encodeId=301310e8203ae, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93086392192, createdName=ms6000000137745448, createdTime=Wed Dec 08 20:31:10 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070958, encodeId=e0ae10e095834, content=学习了，很有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b1a2235083, createdName=121304f3m09暂无昵称, createdTime=Wed Nov 17 06:20:36 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065595, encodeId=8fd3106559515, content=指南很新，正是我非常需要的，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=729f5602417, createdName=苹果🍎ms2000000115919235, createdTime=Sun Oct 31 21:00:55 CST 2021, time=2021-10-31, status=1, ipAttribution=)]
    2021-12-08 ms6000000137745448

    实用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1204233, encodeId=5f0d12042331f, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14da2397323, createdName=12347d7bm83(暂无昵称), createdTime=Sun Mar 20 06:56:21 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080637, encodeId=1246108063e69, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:52:25 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078203, encodeId=301310e8203ae, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93086392192, createdName=ms6000000137745448, createdTime=Wed Dec 08 20:31:10 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070958, encodeId=e0ae10e095834, content=学习了，很有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b1a2235083, createdName=121304f3m09暂无昵称, createdTime=Wed Nov 17 06:20:36 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065595, encodeId=8fd3106559515, content=指南很新，正是我非常需要的，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=729f5602417, createdName=苹果🍎ms2000000115919235, createdTime=Sun Oct 31 21:00:55 CST 2021, time=2021-10-31, status=1, ipAttribution=)]
    2021-11-17 121304f3m09暂无昵称

    学习了，很有收获

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1204233, encodeId=5f0d12042331f, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=14da2397323, createdName=12347d7bm83(暂无昵称), createdTime=Sun Mar 20 06:56:21 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080637, encodeId=1246108063e69, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0eb95611909, createdName=龙珠, createdTime=Thu Dec 16 09:52:25 CST 2021, time=2021-12-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1078203, encodeId=301310e8203ae, content=实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=93086392192, createdName=ms6000000137745448, createdTime=Wed Dec 08 20:31:10 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070958, encodeId=e0ae10e095834, content=学习了，很有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9b1a2235083, createdName=121304f3m09暂无昵称, createdTime=Wed Nov 17 06:20:36 CST 2021, time=2021-11-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1065595, encodeId=8fd3106559515, content=指南很新，正是我非常需要的，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=729f5602417, createdName=苹果🍎ms2000000115919235, createdTime=Sun Oct 31 21:00:55 CST 2021, time=2021-10-31, status=1, ipAttribution=)]
    2021-10-31 苹果🍎ms2000000115919235

    指南很新，正是我非常需要的，谢谢

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2021 AIOM_AMD_SIE_SIF多学科共识意见：新发糖尿病胰腺癌的早期预测

意大利肿瘤医学协会(AIOM,Italian Association of Medical Oncology) · 2021-05-18

互联网医院糖尿病线上管理中国专家共识

中国老年保健协会 · 2021-05-19

SGLT-2抑制剂和GLP-1激动剂对成人2型糖尿病临床实践指南

暂未更新 · 2021-05-13

成人糖尿病患者血压管理专家共识

上海市医学会(ShangHai Medical Association) · 2021-02-04

2021 ABCD/RA指南：器官移植术后糖尿病的检测与管理

英国肾脏病协会(RA,The Renal Association) · 2021-01-12

结核病与糖尿病共病的治疗管理专家共识

国家感染性疾病临床医学研究中心 · 2021-01-10

拓展阅读

2009 中国糖尿病护理及教育指南

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2009-10-30

2010CARI 2型糖尿病患者的肾功能评估

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010CARI 2型糖尿病患者中慢性肾脏病的预防和管理

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010 AOA（POA）糖尿病患者眼部健康

美国视觉协会(AOA,American Optometric Association) · 2010-01-01

中国糖尿病医学营养治疗指南 （2010年）

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2010-01-01

运动与2型糖尿病联合声明

美国糖尿病学会(ADA,American Diabetes Association) · 2010-01-01